
Gout arthritis, driven by pathological hyperuricemia, demands early-stage, non-invasive uric acid (UA) quantification in biological fluids at concentrations far below the micromolar thresholds accessible to existing electrochemical sensors. Here, we report the synthesis, physicochemical characterization, and electroanalytical application of a molecularly imprinted porous aromatic framework, miPAF-6(TEA), deposited on disposable gold screen-printed electrodes (Au-SPEs) for sub-nanomolar UA detection in human saliva and serum. Three PAF-6 variants were prepared by nucleophilic aromatic substitution (SNAr) polycondensation of cyanuric chloride with piperazine, PAF-6(KC) and PAF-6(TEA) as non-imprinted controls using K2CO3 and triethanolamine (TEA) as respective bases, and miPAF-6(TEA) incorporating UA as a molecular template, to demonstrate that base identity governs network morphology and interfacial electrochemical properties. Powder X-ray diffraction reveals a previously unreported crystallographic imprinting mechanism: during polycondensation, UA crystals act as structure-directing agents, organizing the PAF-6 network around the monoclinic P21/a UA lattice; upon template extraction, UA-derived Bragg reflections selectively disappear, two intrinsic framework ordering peaks emerge (2θ = 21.6° and 24.6°), and a subset of UA-commensurate periodicities are permanently encoded into the covalent backbone, providing direct diffraction-level proof of molecular memory. ATR-FTIR confirms template removal, and SEM surface analysis reveals that miPAF-6(TEA) uniquely exhibits a rough, leptokurtic surface profile, reflecting the sharp-walled recognition cavities generated by extraction. Electrochemical characterization demonstrates a reduction in charge-transfer resistance, with a heterogeneous rate constant K° = 7.7 × 10−3 cm s−1 and electroactive area exceeding the geometric area (% Areal = 111.57%). Differential pulse voltammetry quantification of UA over a 1–1000 nM linear range yields a sensitivity of 2.01 μA cm−2 nM−1, LOD of 0.11 nM, and LOQ of 0.35 nM (R2 = 0.99), with strong discrimination against ten salivary interferents, including the structurally analogous allantoin (4.3-fold selectivity ratio). The sensor retains 93% of its initial response after 13 days and delivers validated mean recoveries of 97.9% (RSD ≤ 4.7%) in saliva and 87.8% (RSD ≤ 4.0%) in serum. This work establishes crystal-structure-directed molecular imprinting within porous aromatic frameworks (PAF-6) as a powerful and generalizable strategy for fabricating high-performance, selective electrochemical sensors for biomarker detection at the point of care.
Selenium–iodine co-substitution enables HOCl-activated BOIMPY fluorescence while preserving photodynamic activity under inflammatory oxidative conditions.
Vertically oriented ZnO NR-based hydrazine sensors offer enhanced sensing performance and high stability, and are suitable for practical use in water samples.
Correction for ‘Development of an integrated biosafety platform enabling parallel in vivo imaging under uniform gaseous and optical conditions for infectious disease and preclinical research’ by Ding Gao et al. , Sens. Diagn. , 2026, 5 , 1261–1275, https://doi.org/10.1039/d6sd00064a.
The capability of gas sensing platforms to detect disease-specific volatile organic compound (VOCs) biomarkers in in body-emitted gases has opened new frontiers for non-invasive and real-time disease diagnostics. One-dimensional (1D)...